These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. The incidence of Duchenne muscular dystrophy in eastern Austria. The controversy regarding CK screening. Hauser E; Toifl K; Mad A; Bittner R Wien Klin Wochenschr; 1993; 105(15):433-6. PubMed ID: 8104369 [TBL] [Abstract][Full Text] [Related]
24. [Systematic neonatal detection of Duchenne's muscular dystrophy. Results after 10 years' of experience in Lyons (France)]. Plauchu H; Cordier MP; Carrier HN; Dellamonica C; Dorche C; Guibaud P; Lauras B; Cotte J; Robert JM J Genet Hum; 1987 Aug; 35(4):217-30. PubMed ID: 3655748 [TBL] [Abstract][Full Text] [Related]
25. An examination of some factors influencing creatine kinase in the blood of patients with muscular dystrophy. Jackson MJ; Round JM; Newham DJ; Edwards RH Muscle Nerve; 1987 Jan; 10(1):15-21. PubMed ID: 3561434 [TBL] [Abstract][Full Text] [Related]
30. Diagnosis of Duchenne muscular dystrophy: parents' experiences and satisfaction. Green JM; Murton FE Child Care Health Dev; 1996 Mar; 22(2):113-28. PubMed ID: 8820016 [TBL] [Abstract][Full Text] [Related]
31. Dilution effect on serum creatine kinase in carriers of Duchenne muscular dystrophy. Simpson AC; Holmes D; Pennington RJ Ann Clin Biochem; 1979 Jan; 16(1):54-5. PubMed ID: 420506 [No Abstract] [Full Text] [Related]
32. Recognising and preventing Duchenne muscular dystrophy. Gardner-Medwin D Br Med J (Clin Res Ed); 1983 Oct; 287(6399):1083-4. PubMed ID: 6414575 [No Abstract] [Full Text] [Related]
33. Muscular dystrophy. Part I: Serum enzymes in the Duchenne muscular dystrophy and other neuromuscular disorders. Narayanan I; Ramakrishna Rao P; Balakrishnan S; Subrahmanyam K Indian J Med Res; 1974 Apr; 62(4):598-604. PubMed ID: 4435868 [No Abstract] [Full Text] [Related]
34. Serum creatine kinase activity and its isoenzymes in Duchenne muscular dystrophy. Chen CF; Lien IN; Lu FJ Taiwan Yi Xue Hui Za Zhi; 1983 Feb; 82(2):265-73. PubMed ID: 6576099 [No Abstract] [Full Text] [Related]
36. Duchenne muscular dystrophy: issues in expanding newborn screening. Kemper AR; Wake MA Curr Opin Pediatr; 2007 Dec; 19(6):700-4. PubMed ID: 18025940 [TBL] [Abstract][Full Text] [Related]
37. [Serum creatine kinase activity in patients with Duchenne-type dystrophy and in their mothers following physical effort]. Hetnarska L Neurol Neurochir Pol; 1971; 5(5):653-7. PubMed ID: 5161075 [No Abstract] [Full Text] [Related]
38. [Possibility of prenatal diagnosis of progressive muscular dystrophy: evaluation of creatine kinase activity in serum and the capping of lymphocytes]. Venturoli A; Sensi A; Baricordi R; Artioli A; Osti L; Mari R; Ferroni G; Lucci M Boll Soc Ital Biol Sper; 1983 Dec; 59(12):1988-94. PubMed ID: 6608363 [TBL] [Abstract][Full Text] [Related]
39. Failure of fetal creatine phosphokinase as a diagnostic indicator of Duchenne muscular dystrophy. Golbus MS; Stephens JD; Mahoney MJ; Hobbins JC; Haseltine FP; Caskey CT; Banker BQ N Engl J Med; 1979 Apr; 300(15):860-1. PubMed ID: 423925 [No Abstract] [Full Text] [Related]
40. A new method for the analysis of age trends in CPK levels with application to Duchenne muscular dystrophy. Lange K; Zatz M Hum Hered; 1979; 29(3):154-60. PubMed ID: 468274 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]